SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Maze Therapeutics, a company translating genetic insights into new precision medicines, today revealed its first three lead therapeutic candidates in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback